---
title: "Pharmaron Beijing Shares Jump After Eli Lilly Pledges $200 Million Investment in Partnership"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278866533.md"
description: "Shares of Pharmaron Beijing surged over 13% after announcing a partnership with Eli Lilly, which includes a $200 million investment to manufacture a diabetes and weight-loss drug, orforglipron. The stock closed 8.4% higher, marking its largest single-day rise since September. Eli Lilly aims to gain regulatory approval for the drug in over 40 countries, with the partnership seen as a significant milestone for Pharmaron's business. Eli Lilly is also expanding its supply chain capacity in China, with nearly $6 billion in investments in the country."
datetime: "2026-03-12T10:45:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278866533.md)
  - [en](https://longbridge.com/en/news/278866533.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278866533.md)
---

# Pharmaron Beijing Shares Jump After Eli Lilly Pledges $200 Million Investment in Partnership

Pharmaron Beijing Shares Jump After Eli Lilly Pledges $200 Million Investment in Partnership

### Related Stocks

- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [562050.CN](https://longbridge.com/en/quote/562050.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)

## Related News & Research

- [Xuanzhu Biopharm Wins Green Light for Phase III Anaprazole Trial in H. pylori](https://longbridge.com/en/news/282752451.md)
- [Cutia Therapeutics’ Botox Rival Meets Phase III Goals in China](https://longbridge.com/en/news/282464943.md)
- [RemeGen Drug Approved For Cancer Indication](https://longbridge.com/en/news/282478668.md)
- [Lilly told to gather more safety info on obesity launch Foundayo](https://longbridge.com/en/news/282739842.md)
- [Eli Lilly Faces Pressure In India As Cheaper GLP-1 Rivals Dent Mounjaro Sales](https://longbridge.com/en/news/282182405.md)